Fundraising Fox

FoRx Therapeutics

Basel, CH · 3 known investors

forxtherapeutics.com

FoRx Therapeutics is a clinical-stage biotechnology company developing small-molecule drugs that target DNA replication stress in treatment-resistant cancers. Its focus is on targeted anticancer therapies within oncology and the DNA Damage Response field.

BiotechDeep TechHealthtech

Investors · 3

Funding

SEC filings, press & company announcements

$50M disclosed across 1 round · 2025

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Frequently asked questions

What does FoRx Therapeutics do?
FoRx Therapeutics is a clinical-stage biotechnology company developing small-molecule drugs that target DNA replication stress in treatment-resistant cancers. Its focus is on targeted anticancer therapies within oncology and the DNA Damage Response field.
Who are FoRx Therapeutics's investors?
FoRx Therapeutics's investors include Novartis Venture Fund, Pfizer Venture Investments, M Ventures.
How much funding has FoRx Therapeutics raised?
FoRx Therapeutics has disclosed $50M raised across 1 round.
Where is FoRx Therapeutics headquartered?
FoRx Therapeutics is headquartered in Basel, CH.